Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
- The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.
- Until today, there were no stents or drug-coated balloons approved for use below the knee in the U.S.
- The Esprit BTK System is a first-of-its-kind dissolvable stent and is comprised of material similar to dissolving sutures.
- That's why we're revolutionizing treatments with resorbable scaffold technology below the knee," said Julie Tyler, senior vice president of Abbott's vascular business.